Abstract: This paper presents a highly efficient DC-DC Pulse Frequency Modulation (PFM) boost converter, tailored for low-power energy harvesting applications, utilizing a recursive voltage supply ...
The U.S. economy grew at a rapid rate of 4.3% in the third quarter of this year, according to an estimate released Tuesday by the federal Bureau of Economic Analysis. The estimate, which had been ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...
Recursion Pharmaceuticals, Inc. (RXRX) recently received a notable upgrade from JP Morgan analyst Eric Joseph, who shifted his rating to “Overweight” on December 17, 2025. This upgrade comes as the ...
xRFM is a scalable implementation of Recursive Feature Machines (RFMs) optimized for tabular data. This library provides both the core RFM algorithm and a tree-based extension (xRFM) that enables ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback